A study to Assess the awareness of the complication of type 2 Diabetes Mellitus and to evaluate the effectiveness of counselling program for primary prevention of Type 2 DM in young adult
DOI:
https://doi.org/10.58260/j.nras.2202.0105Keywords:
Type 2 Diabetes Mellitus, Primary prevention, counselling programAbstract
The rapidly increasing number of incidences, severity, its complication, and the socio-economic burden greatly demonstrate the need and importance of the preventive action for type 2 diabetes mellitus. It has been become important to emphasize the call for the primary prevention. Objectives of the study is to assess the awareness of cause complication and prevention of about type 2 diabetes mellitus among young adults, to evaluate and assess the effectiveness of a counselling program regarding causes, complication and prevention for the primary prevention of type 2 Diabetes mellitus, and to find the relationship between socio-demographical variables and level of awareness on diabetes mellitus. For this study an evaluative approach was considered. The pre-experimental design consists of pre-test and post-test observation made on different days with only one selected group and without a control group. The overall mean awareness score present in pre-test is 46.1 and the post-test 82.2% and there was enhancement of knowledge score found to be 36.4%. Therefore, it was established that there was significant increase in the awareness level after the counselling program. From this study it was found that demographic variables like educational status, family income, age group has impact on the knowledge of the respondent. The present study has demonstrated that counselling program is sufficiently effective and viable for achievement of the goal for primary prevention of Diabetes Mellitus in ordinary community
References
Joshlin E. The prevention of diabetes mellitus. JAMA 76: 79-84, 1921
Wild Sarah, Sircee R et al. Global prevalence of Diabetes: Estimate for the 2000 and projection for 2030. Diabetes Care, 27(5): 1047-1053, 2004
Morris RD, Rimm DL, Hartz AJ, Kalkhoff RK, Rimm AA: Obesity and heredity in the etiology of non-insulin dependent diabetes mellitus in 32,662 adult white women. Am J Epidemiol130:112-121, 1989
Van Dam RM, Rimm EB, Willett WC, Stampher MJ, and Hu FB: Dietary patterns and risk for type 2 Diabetes Mellitus in U.S. men. Ann Intern Med 136:201-209, 2002.
McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 382-386.
Mohan V. Sharp PS, Cloke HR, Burrin JM, Schumer B, Kohner EM. Serum Immunoreactive insulin responses to a glucose load in Asian Indian and European type 2 (non-insulin-dependent) diabetic patient and control subjects. Diabetogia 1886; 29: 235-237.
Sratton IM, Adler Al, Neil HA, Mathews DR, Manley SE, Cull CA, Hadden D, Turner R: Association of Glycaemia with macrovascular and microvascular complication of type 2 diabetes (UKPDS 35). Br Med J 321: 405-412, 2000.
Mohan D, Raj D, Shantirani CS et al. Awareness and knowledge of Diabetes in Chennai – the Chennai Urban Rural Epidemiology study (CURES – 9). J Assoc Physicians India 2005; 283-7.
American Diabetes Association. Economic cost of Diabetes in the US in 2002. Diabetes Care. 2003; 26: 917-932
Unger R.H.: Reinventing type 2 Diabetes Mellitus: Pathogenesis, treatment and Prevention. JAMA 299. (10):1185-1187: 2008.
Lee Y, Hirose H, Ohneda M et al: B-cell lipotoxicity in the pathogenesis of non-insulin dependent Diabetes Mellitus of obese rats: impairment in adipocyte-beta cell relationships. Proc Natl Acad Sci US A 91. (23): 10878 -10882.1994.
Knowler W.C. Barrett-Corner E, Fowelr S. E. et al: Reduction of incidence of type 2 Diabetes by changes in Lifestyle Invention or Metformin. New Eng J Med 346. 393-403. 2002
Tuomilehto J., Lindstorm J, Erikson J. G. et al: Prevention of type 2 Diabetes by changes in lifestyle among subject with impaired glucose tolerance. N Eng J med 344. 1343-1350. 2001
Pan X R, Li G W., Hu Y. H. et al: Effect of Diet and Exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing and diabetes study. Diabetes Care 20. 537-544. 1997
UKPDS Group. UK Prospective diabetes study 16: Overview of six years therapy of type 2 Diabetes – A progressive disease – Diabetes 1995; 44: 1249-58
The Diabetes Prevention Program Research Group. The Diabetes Prevention Program. Design and methods for clinical trial in prevention of type 2 diabetes mellitus. Diabetes Care 1999; 22: 623-24.
Sicree R., Shaw J., Zimmet P et al. Diabetes and Impaired glucose tolerance. Diabetes Atlas. International Diabetes Federation. 3rd Edition. Belgium: International Diabetes Federation; 2006: 15-103.
Ahuja MMS. Epidemiological studies on Diabetes Mellitus in India. In: Ahuja MMS, Editor. Epidemiology of diabetes in developing countries. 1979: 29-38.
Raman kutty V, Joseph A. Soman CR et al. High prevalence of type 2 Diabetes in an urban settlement in Kerela, India. Ethn Health 1999; 231-9.
Shah SK, Saikia M. Burman NN, Snehalata et al. High prevalence of type 2 Diabetes in urban population in North-eastern India. Int J Diabetes Dev Countries 1999; 19: 144-7.
Zargar AH, Khan AK, Masoodi SR et al. High prevalence of type 2 Diabetes and impaired glucose tolerance in the Kashir valley of the Indian subcontinent. Diabetes Res Clin Pract 2000; 47: 135-6.
Ramchandran A, Snehalatha C, Kapur A, Vijay V et al. Diabetes epidemiology study group in India. High prevalence of Diabetes and impaired glucose tolerance in India: National Urban society survey. Diabetologia 2001; 44: 1094-101.
Gupta A, Gupta R, Sarna M et al. Prevalence of Diabetes and impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res Clin Pract 2003; 61: 69-76.
Menon VU, Kumar KV, Gilchrist A et al. Prevalence of known and undetected diabetes and associated risk factor. Diabetes Res Clin Pract 2006; 74: 289-94.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.